We will exhibit at "BioJapan 2021" held at Pacifico Yokohama from October 13th to 15th. The latest information of our technology is exhibited, including neurological disorder models with patient-derived iPS cell lines, evaluation systems for muscle contractile force, and live-cell imaging chamber for microscopic observation.

Our project was adopted as a "2021 Kyoto Economic Gardening Support Enhancement Project" of KYOTO Industrial Support Organization 21.

The Japan External Trade Organization (JETRO) has released a video interview with our CEO.
JETRO has released a promotional video to introduce the innovation ecosystem in the life science field at the center of western Japan, Kansai region to the world. Together with Bayer in Kobe and AstraZeneca in Osaka, SCAD (Stem Cell & Device Laboratory, Inc.) in Kyoto was introduced in the promotional video.
Kensuke Kato, PhD, CEO of SCAD, is interviewed and explains an overview of the company's activities, development of iPS cell-based disease model cells for rare diseases, and drug discovery using these cells.

JETRO Global Channel, “Life Science at KYOTO, OSAKA, KOBE”

We will exhibit at "BioJapan 2020" held at Pacifico Yokohama from October 14th to 16th.

A co-authored paper on research using our neuronal devices has been published in Nature Communications.

The paper is about a study by Japanese researchers including Associate Professor Ikuo Suzuki of Tohoku Institute of Technology, our technical advisor, and ETH Zurich. It stated that by culturing iPS-derived neurons in three dimensions on oriented fibers using our cell device, the functionality is enhanced compared to two-dimensional culture, and that it is extremely effective in functional analysis of nerve cell populations.

Nature Communications 11, Article number:4854 (2020)

Prof. Norio Nakatsuji, Chief Advisor, received "Future Creation Invention Award".

Our project was adopted as a "2020 Corporate Forest / Industry-Academia Forest Promotion Project" of KYOTO Industrial Support Organization 21.

We are selected as a bio-venture to be supported by the Ministry of Economy, Trade and Industry in "2020 Regional Enterprise Innovation Support Project".

We will give a poster presentation on "Development of a new drug efficacy evaluation method for center and peripheral neural networks using oriented nanofiber devices" in collaboration with Associate Professor Ikuo Suzuki of Tohoku Institute of Technology, our joint research partner, at the 93rd Annual Meeting of the Japanese Pharmacological Society (Pacifico Yokohama, March 16-18, 2020)

Our senior researcher Kinoshita will give a general presentation on the theme of he "Application of oriented fiber scaffold in micro electrode array (MEA) assay using human iPS cell-derived neurons" at the 11th Annual Meeting of the Japan Safety Pharmacology Study Group (2020/2 / 28-29).

Our efforts for rare diseases were covered and broadcasted as news in "NHK / Kansai NEWS WEB (broadcast on January 3, 2020)".

An article about our efforts for rare diseases was published in "Nihon Keizai Shimbun Electronic Edition / Nikkei Sangyo Shimbun (December 23, 2019)".

An article about our efforts for rare diseases was published in "Nikkei Biotech ONLINE (December 16, 2019)".

We have entered into a joint research agreement with Kyoto Prefectural University of Medicine regarding the development of a disease model aimed at developing a treatment for Charcot-Marie-Tooth disease, which is one of the intractable hereditary neurological diseases.